HemaSphere (Jun 2022)

PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY

  • T. Ionova,
  • O. Vinogradova,
  • Y. Kochkareva,
  • E. Ado,
  • K. Kaplanov,
  • M. Shirokova,
  • T. Shelekhova,
  • A. Levanov,
  • A. Kopylova,
  • O. Li,
  • T. Mitina,
  • O. Rukavitsyn,
  • P. Simashova,
  • L. Anchukova,
  • E. Babich,
  • D. Dasheeva,
  • M. Demchenkova,
  • S. Dubov,
  • T. Esenina,
  • L. Ivanova,
  • T. Kravchuk,
  • E. Rimashevskaya,
  • N. Saraeva,
  • M. Savinova,
  • S. Volkova,
  • N. Porfirieva,
  • T. Nikitina

DOI
https://doi.org/10.1097/01.HS9.0000850916.45282.84
Journal volume & issue
Vol. 6
pp. 1892 – 1893

Abstract

Read online

No abstracts available.